These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15723758

  • 1. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation.
    Ramos EJ, Meguid MM, Campos AC, Coelho JC.
    Nutrition; 2005 Feb; 21(2):269-79. PubMed ID: 15723758
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis Ch.
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [Abstract] [Full Text] [Related]

  • 3. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.
    Hallschmid M, Benedict C, Born J, Fehm HL, Kern W.
    Physiol Behav; 2004 Oct 30; 83(1):55-64. PubMed ID: 15501491
    [Abstract] [Full Text] [Related]

  • 4. The MONA LISA hypothesis in the time of leptin.
    Bray GA, York DA.
    Recent Prog Horm Res; 1998 Oct 30; 53():95-117; discussion 117-8. PubMed ID: 9769705
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of melanocortin MC3 and MC4 receptor mRNAs by neuropeptide Y neurons in the rat arcuate nucleus.
    Mounien L, Bizet P, Boutelet I, Vaudry H, Jégou S.
    Neuroendocrinology; 2005 Oct 30; 82(3-4):164-70. PubMed ID: 16508337
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
    Levens NR, Della-Zuana O.
    Curr Opin Investig Drugs; 2003 Oct 30; 4(10):1198-204. PubMed ID: 14649211
    [Abstract] [Full Text] [Related]

  • 13. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
    Dube MG, Kalra SP, Kalra PS.
    Peptides; 2006 Sep 30; 27(9):2239-48. PubMed ID: 16759748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR.
    Neuropeptides; 1999 Oct 30; 33(5):329-38. PubMed ID: 10657510
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Omega-3 fatty acids improve appetite in cancer anorexia, but tumor resecting restores it.
    Goncalves CG, Ramos EJ, Romanova IV, Suzuki S, Chen C, Meguid MM.
    Surgery; 2006 Feb 30; 139(2):202-8. PubMed ID: 16455329
    [Abstract] [Full Text] [Related]

  • 19. Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins.
    Rahmouni K, Haynes WG.
    Bioessays; 2001 Dec 30; 23(12):1095-9. PubMed ID: 11746228
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.
    Williams G, Harrold JA, Cutler DJ.
    Proc Nutr Soc; 2000 Aug 30; 59(3):385-96. PubMed ID: 10997654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.